HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Suzuki Selected Research

Sulfadiazine (Sulphadiazine)

2/2015CXCL9 is important for recruiting immune T cells into the brain and inducing an accumulation of the T cells to the areas of tachyzoite proliferation to prevent reactivation of chronic cerebral infection with Toxoplasma gondii.
7/2014VCAM-1/α4β1 integrin interaction is crucial for prompt recruitment of immune T cells into the brain during the early stage of reactivation of chronic infection with Toxoplasma gondii to prevent toxoplasmic encephalitis.
10/2012Toxoplasma gondii antigens recognized by IgG antibodies differ between mice with and without active proliferation of tachyzoites in the brain during the chronic stage of infection.
12/2010Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection.
6/2005Importance of CD8(+)Vbeta8(+) T cells in IFN-gamma-mediated prevention of toxoplasmic encephalitis in genetically resistant BALB/c mice.
8/2004Gamma interferon production, but not perforin-mediated cytolytic activity, of T cells is required for prevention of toxoplasmic encephalitis in BALB/c mice genetically resistant to the disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Suzuki Research Topics

Disease

50Neoplasms (Cancer)
01/2022 - 01/2002
35Breast Neoplasms (Breast Cancer)
01/2022 - 03/2002
26Infections
04/2022 - 08/2002
20Peritonitis
01/2021 - 01/2011
15Stroke (Strokes)
07/2020 - 10/2002
15Inflammation (Inflammations)
12/2019 - 11/2006
14Hypoxia (Hypoxemia)
02/2022 - 08/2006
9Cysts
06/2020 - 04/2010
9Encephalitis (Encephalitis, Rasmussen)
07/2014 - 02/2002
8Neoplasm Metastasis (Metastasis)
01/2022 - 07/2005
8Persistent Infection
04/2021 - 04/2007
8Peritoneal Fibrosis
01/2021 - 03/2010
8Fibrosis (Cirrhosis)
01/2019 - 03/2010
8Ischemic Stroke
01/2016 - 11/2004
6Ischemia
11/2012 - 04/2002
5Chronic Kidney Failure (Chronic Renal Failure)
07/2022 - 10/2011
5Wounds and Injuries (Trauma)
01/2021 - 07/2003
5Hemorrhage
01/2011 - 04/2002
5Thrombosis (Thrombus)
01/2007 - 04/2002
4Nausea
04/2020 - 09/2009
4Seizures (Absence Seizure)
01/2019 - 01/2007
4Autoimmune Diseases (Autoimmune Disease)
01/2017 - 03/2005
4Renal Insufficiency (Renal Failure)
01/2017 - 03/2005
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2015 - 06/2002
4Abdominal Pain (Pain, Abdominal)
12/2013 - 01/2011
4Graft vs Host Disease (Graft-Versus-Host Disease)
11/2009 - 09/2005
3Insulin Resistance
02/2022 - 01/2017
3Sarcopenia
08/2020 - 01/2020
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
08/2020 - 01/2020
3MELAS Syndrome (Syndrome, MELAS)
12/2018 - 01/2007
3Lymphatic Metastasis
12/2017 - 07/2005
3Necrosis
01/2017 - 01/2012
3Spasm (Spasms)
01/2017 - 08/2014
3Brain Ischemia (Cerebral Ischemia)
01/2016 - 04/2004
3Cardiotoxicity
11/2015 - 04/2002
3Anemia
08/2015 - 10/2003
3Adenocarcinoma
05/2014 - 03/2011
3Carcinoma (Carcinomatosis)
05/2014 - 08/2010
3Thrombocytopenia (Thrombopenia)
06/2012 - 10/2003
3Acute Kidney Injury (Acute Renal Failure)
06/2012 - 03/2005
3Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2012 - 01/2011
3Cerebral Hemorrhage
01/2010 - 04/2002
3Disease Progression
11/2009 - 10/2009

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
12/2017 - 03/2002
15Trastuzumab (Herceptin)FDA Link
11/2015 - 04/2002
11Hormones (Hormone)IBA
12/2020 - 03/2003
10Tissue Plasminogen Activator (Alteplase)FDA Link
01/2016 - 06/2002
9Pharmaceutical PreparationsIBA
05/2021 - 03/2005
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2021 - 05/2006
8Matrix Metalloproteinases (MMPs)IBA
02/2021 - 02/2002
8Messenger RNA (mRNA)IBA
04/2020 - 03/2010
7Biomarkers (Surrogate Marker)IBA
01/2021 - 03/2010
7Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 11/2007
7PerforinIBA
06/2020 - 08/2004
7CytokinesIBA
10/2011 - 01/2002
7Interferon-gamma (Interferon, gamma)IBA
10/2011 - 08/2004
6Indicators and Reagents (Reagents)IBA
12/2020 - 11/2007
6Complement System Proteins (Complement)IBA
12/2018 - 05/2012
6Monoclonal AntibodiesIBA
03/2017 - 04/2002
6Sulfadiazine (Sulphadiazine)FDA Link
02/2015 - 08/2004
5AntibodiesIBA
04/2021 - 11/2009
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 07/2005
5ZymosanIBA
01/2021 - 05/2012
5Vascular Endothelial Growth Factor CIBA
01/2019 - 04/2009
5ErbB Receptors (EGF Receptor)IBA
11/2015 - 08/2005
4Immunoglobulin G (IgG)IBA
04/2021 - 12/2010
4FibrinIBA
01/2021 - 07/2002
4Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2021 - 04/2007
4AnthracyclinesIBA
10/2019 - 04/2002
4Dialysis SolutionsIBA
01/2019 - 03/2010
4human ERBB2 proteinIBA
12/2017 - 10/2003
4taxaneIBA
08/2013 - 10/2003
4InterferonsIBA
09/2010 - 02/2002
4NF-kappa B (NF-kB)IBA
08/2010 - 05/2007
3Oxygen (Dioxygen)IBA
11/2021 - 01/2018
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2019 - 07/2002
3Epirubicin (Ellence)FDA LinkGeneric
10/2019 - 07/2002
3Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2019 - 07/2010
3Arginine (L-Arginine)FDA Link
12/2018 - 01/2007
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 05/2012
3Angiogenesis InhibitorsIBA
10/2016 - 07/2009
3Anticonvulsants (Antiepileptic Drugs)IBA
04/2015 - 01/2007
3Small Interfering RNA (siRNA)IBA
12/2013 - 01/2013
3CollagenIBA
11/2012 - 01/2002
3AntigensIBA
10/2012 - 06/2005
3Lactic Acid (Lactate)FDA LinkGeneric
03/2012 - 07/2010
3Fibrinolytic Agents (Antithrombotic Agents)IBA
01/2012 - 04/2002
3FibrinolysinFDA Link
01/2012 - 01/2002

Therapy/Procedure

49Therapeutics
01/2022 - 01/2002
31Peritoneal Dialysis
07/2022 - 03/2010
10Drug Therapy (Chemotherapy)
01/2013 - 01/2002
6Catheters
01/2020 - 12/2013
6Transplantation
01/2011 - 09/2005
4Segmental Mastectomy (Lumpectomy)
01/2022 - 04/2010
4Conservative Treatment
07/2020 - 09/2008
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
11/2009 - 03/2005
3Neoadjuvant Therapy
12/2020 - 01/2003
3Thrombolytic Therapy
12/2015 - 04/2002
3Aftercare (After-Treatment)
06/2012 - 10/2003
3Treatment Delay
01/2012 - 01/2010